Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCE: Reduced Immunosuppression in Senior Renal Transplant Recipients
NCT02453867Phase 4Unknown
- Start
- Dec 2017
- Primary completion
- Jul 2018
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in kidney transplant (2 arms). Primary endpoint: Combined efficacy endpoint (BPAR, graft loss and death) at 12 months. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NCT02453867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453867.